Mukunthan Murthi

Mukunthan Murthi

Auto-generated profile, based on publicly available information

Mukunthan Murthi

Division of Cardiology, Cook County Health, Chicago, IL (M.M., A.V.).

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2022 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Closed access
PDF file
DPDae Yong Park
Dae Yong Park
SASeokyung An
Seokyung An
MMMukunthan Murthi
Mukunthan Murthi
AKajoe kattoor
ajoe kattoor
AKAmandeep Kaur
Amandeep Kaur
AVAviral Vij
Aviral Vij

11 December 2021 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
MMMukunthan Murthi
Mukunthan Murthi
HSHafeez Shaka
Hafeez Shaka
ZEZain El-Amir
Zain El-Amir
SVSujitha Velagapudi
Sujitha Velagapudi
AJAbdul Jamil
Abdul Jamil
AKAsim Kichloo
Asim Kichloo
Background: Acute pulmonary embolism (PE) is a common cause for hospitalization associated with significant mortality and morbidity. Disorders of calcium metabolism are a frequently encountered medical problem. The effect of hypocalcemia is not well defined on the outcomes of patients with PE. We aimed to identify the prognostic value of hypocalcemia in hospitalized PE patients utilizing the 2017 Nationwide Inpatient Sample (NIS). Methods: In this retrospective study, we selected patients with a primary diagnosis of Acute PE using ICD 10 codes. They were further stratified based on the presence of hypocalcemia. We primarily aimed to compare in-hospital mortality for PE patients with and without hypocalcemia. We performed multivariate logistic regression analysis to adjust for potential confounders. We also used propensity‐matched cohort of patients to compare mortality. Results: In the 2017 NIS, 187,989 patients had a principal diagnosis of acute PE. Among the above study group, 1565 (0.8%) had an additional diagnosis of hypocalcemia. 12.4% of PE patients with hypocalcemia died in the hospital in comparison to 2.95% without hypocalcemia. On multivariate regression analysis, PE and hypocalcemia patients had 4 times higher odds (aOR-4.03, 95% CI 2.78–5.84, p < 0.001) of in-hospital mortality compared to those with only PE. We observed a similarly high odds of mortality (aOR = 4.4) on 1:1 propensity-matched analysis. The incidence of acute kidney injury (aOR = 2.62, CI 1.95–3.52, p < 0.001), acute respiratory failure (a0R = 1.84, CI 1.42–2.38, p < 0.001), sepsis (aOR = 4.99, CI 3.08–8.11, p < 0.001) and arrhythmias (aOR = 2.63, CI 1.99–3.48, p < 0.001) were also higher for PE patients with hypocalcemia. Conclusion: PE patients with hypocalcemia have higher in-hospital mortality than those without hypocalcemia. The in-hospital complications were also higher, along with longer length of stay.

24 September 2022 in The American Journal of Cardiology
Verified
Journal Article
Closed access
MMMukunthan Murthi
Mukunthan Murthi
SVSujitha Velagapudi
Sujitha Velagapudi
DPDae Yong Park
Dae Yong Park
HSHafeez Shaka
Hafeez Shaka

28 April 2022 in Cureus
Verified
Journal Article
Open access
MMMukunthan Murthi
Mukunthan Murthi
SVSujitha Velagapudi
Sujitha Velagapudi
BSBharosa Sharma
Bharosa Sharma
OEOlisa Ezegwu
Olisa Ezegwu
EAEmmanuel Akuna
Emmanuel Akuna
UVUfuk Vardar
Ufuk Vardar
The transcatheter aortic valve replacement (TAVR) procedure has been increasingly utilized in the management of aortic stenosis among the elderly. In this study, we sought to assess the hospital outcomes and major adverse events (MAEs) associated with TAVR in patients aged ≥80 years compared to those aged <80 years. We performed a retrospective observational study using the National Inpatient Sample in 2018. We divided TAVR patients into two cohorts based on age, namely, ≥80 years old and <80 years old. The primary outcomes included the comparison of in-hospital mortality and MAEs in the two cohorts. We identified 63,630 patients who underwent TAVR from January 1 to December 31, 2018. Among them, 35,115 (55%) were ≥80 years and 28,515 (45%) were <80 years of age. There was a higher rate of post-procedural in-hospital mortality in patients ≥80 years old (1.6% vs. 1.1%, adjusted odds ratio (aOR) = 1.56, [confidence interval (CI) = 1.13-2.16], p = 0.006). They also had higher rates of pacemaker insertion compared to those <80 years old (7.4% vs. 6.5%, aOR = 1.17 [CI = 1-1.35], p = 0.03). On subgroup analysis, the rates of MAEs were not different between the two cohorts (23.8% vs. 23.4%, p = 0.09); however, patients aged ≥80 years who experienced MAEs had higher in-hospital mortality (5.7% vs. 4.3%, aOR = 1.58 [CI = 1.08-2.32], p = 0.01) and shorter length of hospital stay (7.2 vs. 8.7 days, p = 0.03) compared to those aged <80 years. Anemia, liver disease, chronic kidney disease, and previous stroke were associated with higher odds of in-hospital MAEs in both groups. The results of our study show that patients older than 80 years of age undergoing TAVR had higher rates of in-hospital mortality and pacemaker insertion compared to those less than 80 years of age. The rates of MAEs were not significantly different between the two groups.

1 September 2022 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
MMMukunthan Murthi
Mukunthan Murthi
UVUfuk Vardar
Ufuk Vardar
MSMuhammad Khawar Sana
Muhammad Khawar Sana
HSHafeez Shaka
Hafeez Shaka

31 July 2024 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
MMMukunthan Murthi
Mukunthan Murthi
NBNaveen Baskaran
Naveen Baskaran
AMAnisha Memdani
Anisha Memdani
ABAniesh Bobba
Aniesh Bobba
LALaith Ali
Laith Ali
SASteve Attanasio
Steve Attanasio